Author: admin

Exciting New Lineup of Events Unveiled for Barcelona

“Events Unveiled for Barcelona”

Barcelona, Spain – Feb 17, 2025 – The vibrant city of Barcelona is poised to come alive with an exceptional array of Barcelona events that highlight its rich cultural heritage, artistic diversity, and a strong sense of community. From music festivals to art exhibitions, local markets, and culinary showcases, the upcoming season of Barcelona events promises a celebration for everyone to enjoy.

Barcelona Arts Festival

Kicking off the season, the BarcelonaArts Festival will span two weeks, featuring an eclectic mix of local and international artists across various disciplines, including visual arts, theater, and dance. The festival will include interactive workshops where participants can learn from experienced artists, engage in creative practices, and experience firsthand the artistic process. Open-air performances will transform public spaces into vibrant stages, encouraging spontaneous interaction between artists and audiences.

In mid-May, the historic Gothic Quarter will host a magical weekend street fair. This event will feature local artisans showcasing their crafts, from handmade jewelry to traditional Catalan textiles. Attendees can savor the flavors of the region at food stalls offering delectable dishes, including tapas, paella, and local wines. Live music and street performances will enliven the atmosphere, creating a festive environment for families and friends to gather and celebrate local culture. “The Gothic Quarter is a treasure trove of history and creativity, and we’re excited to highlight this unique neighborhood in the lineup of Barcelona events,” said the event coordinator.

Summer Music Series

As summer approaches, the city will come alive with the Summer Music Series, featuring a lineup of outdoor concerts in iconic venues throughout Barcelona. This series will span three months and showcase a diverse array of musical genres, from classical and jazz to pop and electronic. Each concert will celebrate both established and emerging artists, providing a platform for local talent. In addition to performances, the series will include pre-concert workshops, where attendees can engage with musicians and gain insight into their creative processes. “Music has a way of uniting people, and we want to create an inclusive environment where everyone can enjoy and appreciate the power of live performance,” said the music director, emphasizing the importance of community in all Barcelona events.

Barcelona Food Festival

As the summer fades, the Barcelona Food Festival will take center stage, celebrating the city’s diverse and vibrant culinary scene. Over the course of a week, visitors can indulge in a variety of gastronomic experiences, including cooking classes led by renowned chefs, food tastings, and chef-led demonstrations showcasing Catalan cuisine. This festival will not only highlight traditional dishes but also emphasize sustainable practices and local ingredients.

Community Art Walk

In October, the Community Art Walk will take place, providing a unique platform for local artists to showcase their work along designated walking routes throughout the city. This initiative aims to foster connections between artists and the community, encouraging dialogue and collaboration. Participants can engage with artists, learn about their inspirations, and even purchase original works.

Join us in celebrating the spirit of Barcelona through this exciting lineup of events that highlight the best of our culture, art, and community!

Media Contact
Company Name: Dondego
Contact Person: Jakariya Sarkar
Email: Send Email
Phone: 01877448297
Address:Village Hatimpur, P.O. Khalilpur, Uttar Gunaighur, Debidwar, Chattagram Division
City: Cumilla
Country: Bangladesh
Website: https://dondego.es/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Exciting New Lineup of Events Unveiled for Barcelona

Scott Landis’s Groundbreaking Workshop at MegaMix Expo: Redefining Growth for Family-Owned Enterprises

““In today’s fast-paced business environment, entrepreneurs need a clear roadmap to scale their operations without compromising what matters most,” says Alexis Salamanca, COO of Ofiso Solutions Corp.”
Bestselling author and business coach Scott Landis, founder of Awakened Life and the Business Freedom Forum, will headline the Megamix Expo 2025 with a transformative workshop titled “Scaling Family-Owned Businesses Without Sacrifice.” The Megamix Business Expo is a premier networking event in Southern California, fostering professional growth and innovation.

Scott Landis, founder of Awakened Life and the Business Freedom Forum, will present a groundbreaking workshop “Scaling Family-Owned Businesses Without Sacrifice” at the Megamix Expo 2025, scheduled for March 12-13 at Santa Anita Park in Arcadia, California.

Workshop Details

As a distinguished business coach and relationship expert, Landis brings his innovative approach that integrates profound personal development with strategic business growth. His session will focus on essential frameworks for:

• Professional governance

• Succession planning

• Innovative growth strategies

• Change management

• Sustainable scaling

Expert Background

Landis, who leads the prestigious Business Freedom Forum, has developed proprietary tools including the TriMetric Tracking System and Alignment Operating System. His methodology helps entrepreneurs diagnose and resolve complex business challenges while maintaining family harmony. Through his Awakened Life platform, he explores the Four Pillars of Fulfillment: Vitality, Relationships, Freedom, and Impact.

Event Information

The two-day Megamix Expo expects to draw over 10,000 attendees and feature more than 200 exhibitors. VIP Business registrants will receive a complimentary copy of Landis’s latest book “Balancing Act,” enhancing their learning experience with comprehensive insights into successful family business transformation.

About Scott Landis

Scott Landis is an influential business coach and the visionary founder of Awakened Life, where he masterfully integrates profound personal development with strategic business growth Through his flagship program, the Business Freedom Forum, he empowers entrepreneurs using innovative tools like the TriMetric Tracking System and Alignment Operating System to diagnose and resolve complex business challenges.

About Megamix Expo

The San Gabriel Valley Megamix Expo 2025 represents Southern California’s premier business networking event, facilitating professional growth and development through innovative product showcases and extensive networking opportunities.

Media Contact
Company Name: MegaMix Expo
Contact Person: Alexis Salamanca
Email: Send Email
Phone: 6262973613
Address:219 Saint Francis St Apt 11
City: SAN GABRIEL
State: CA
Country: United States
Website: https://www.megamixexpo.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Scott Landis’s Groundbreaking Workshop at MegaMix Expo: Redefining Growth for Family-Owned Enterprises

James Brown, CEO & Founder of Business Accelerator Institute and Perseverance Squared, Interviewed on the Influential Entrepreneur Podcast

Listen to the interview on the Business Innovators Radio Network: Interview with James Brown, CEO & Founder of Business Accelerator Institute and Perseverance Squared

In this episode of Influential Entrepreneurs, host Mike Saunders welcomes James Brown, the CEO and founder of Business Accelerator Institute and Perseverance Squared. James shares his inspiring journey from a challenging upbringing to becoming a lawyer, emphasizing the importance of perseverance—a key trait discussed by Napoleon Hill in “Think and Grow Rich.” He recounts how his parents doubted his ability to succeed after he announced his marriage at 19, motivating him to prove them wrong. Working tirelessly at General Motors while pursuing his education, James illustrates the dedication it takes to achieve one’s goals.

In the world of marketing and sales, grasping the emotional triggers of potential clients is essential. As discussed in the podcast episode with James Brown, individuals are often more motivated to avoid pain than to seek gain. This insight can profoundly shape how businesses develop their marketing strategies and sales techniques.

James emphasizes that the emotional side of the brain plays a critical role in decision-making. While many believe they make logical choices, the reality is that emotions drive our decisions. When confronted with a problem, such as the threat of foreclosure, individuals are not only worried about losing their home; they are also dealing with deeper emotional fears, including the embarrassment of failure, the impact on their family, and the upheaval of their children’s lives.

The podcast highlights a fundamental truth: people will go to greater lengths to avoid pain than to seek gain. This principle can be effectively leveraged in marketing messages. For instance, instead of simply stating, “We can help you stop foreclosure,” a more impactful approach would be to frame the message around the emotional pain of losing a home: “Are you about to lose your home and can’t tell your family you’re going to live on the street?” This type of messaging resonates more deeply with potential clients, prompting them to take action.

To connect effectively with potential clients, businesses should focus on crafting marketing messages that address these emotional triggers. Here are some strategies based on the insights James shared:

  1. Identify Pain Points: Understand the specific fears and challenges your target audience faces. This requires delving into their emotional state and recognizing what keeps them up at night.
  2. Paint a Vivid Picture: Use storytelling to illustrate the consequences of inaction. For example, describe the potential fallout of foreclosure, such as the loss of stability for their family and the emotional toll it takes.
  3. Paint a Vivid Picture of Their Future: Spell out what the best case scenario is and how great that will be for them, then offer solutions
  4. Build Trust: Establish credibility through social proof and testimonials. As James mentions, sending a series of emails that provide value and reinforce your expertise can help build trust and reduce anxiety about the decision to engage your services.
  5. Engage Emotionally: During sales conversations, focus on emotional triggers by asking questions that elicit feelings. For instance, inquire about what losing their home would mean to them and their family, and then discuss the best-case scenario if they choose to work with you.

James shared: “The emotional side is where we make decisions… we make decisions based on emotion.”

Video Link: https://www.youtube.com/embed/t_SUrxqqFUM

About James Brown

James is the CEO/Founder of Business Accelerator Institute and Perseverance Squared where he is a business consultant with a strong background in law. He launched his first business in 1994 and rapidly expanded to multiple top-performing locations reaching $8M in annual revenue. In 2014, James transitioned to coaching, guiding over 350 business owners to significant growth through strategic management and marketing. As a fractional CEO/SLFU Program Manager at How To Manage a Small Law Firm, he launched Small Law Firm University, growing it to $3 million in revenue within a year, and developed a CMO program that generated an additional $2 million annually. With a Business degree from Lindenwood University and a JD from St. Louis University, James is a recognized industry expert and co-author of the best-selling book Shift Happens. He has earned numerous accolades for his legal expertise and business acumen.

Learn more: https://businessaccelerator.institute

https://www.linkedin.com/in/businessacceleratorinstitute/

Media Contact
Company Name: Marketing Huddle, LLC
Contact Person: Mike Saunders, MBA
Email: Send Email
Phone: 7202323112
Country: United States
Website: https://www.AuthorityPositioningCoach.com

Darryl and Alicia Pryor with DNA Financial & Associates Interviewed on Podcast Discussing Breaking the Chains – Becoming Free from Money Myths

Darryl and Alicia discuss money myths

Listen to the interview on the Business Innovators Radio Network: Interview with Darryl and Alicia Pryor With DNA Financial Associates Discussing Breaking the Chains – Freeing Yourself from Money Myths – Business Innovators Radio Network

Darryl and Alicia Pryor from DNA Financial & Associates to discuss the topic of money myths. They dive into common misconceptions that hold people back, particularly the myth that “money is the root of all evil.” Darryl and Alicia explain that this belief stems from a misinterpretation of a biblical phrase and emphasize that money itself is merely a tool. They share insights on how to shift the mindset around money, encouraging listeners to view it as a resource for positive impact—supporting families, investing in personal goals, and enhancing community growth.

Darryl and Alicia Pryor explained a transformative mindset regarding money. A key takeaway is the notion that money should be viewed as a tool and a vehicle for positive impact, rather than something to be feared or avoided.

Darryl emphasizes that money is merely a tool; it is not inherently good or evil. Instead, its impact is determined by how individuals choose to use it. By reframing money as a resource, clients can begin to see it as a means to achieve their goals, support their families, and contribute to their communities. This perspective encourages individuals to consider the positive outcomes that can arise from financial resources, such as:

  • Supporting Families: Money can provide for basic needs, education, and opportunities for family members, creating a stable environment where loved ones can thrive.
  • Investing in Communities: With the right mindset, individuals can use their financial resources to uplift their communities, whether by funding local initiatives, supporting local businesses, or contributing to charitable organizations that address pressing social issues.

Alicia adds to this discussion by highlighting that money can also be seen as a vehicle that drives individuals toward their aspirations. Just as a vehicle transports people to their desired destinations, money can facilitate the journey toward achieving personal and communal goals. This includes:

  • Building Generational Wealth: By using money wisely, individuals can create a legacy of financial stability for future generations, benefiting their families and setting a precedent for responsible financial management within their communities.
  • Philanthropy and Social Responsibility: Wealth can empower individuals to give back. The podcast discusses how increased income can lead to greater contributions to charitable causes, such as supporting the homeless or funding educational programs. This shift in mindset—from viewing wealth as personal gain to seeing it as a means to make a difference—can inspire others to do the same.

They also address common myths surrounding money, such as the belief that “money is the root of all evil.” Darryl and Alicia work with clients to help them overcome these limiting beliefs. They encourage individuals to recognize that fear of money often stems from a lack of understanding or experience in managing it. By educating clients about financial literacy and fostering open discussions about money within families, they can cultivate a healthier relationship with finances.

Darryl & Alicia shared: “At DNA Financial & Associates, we believe everyone deserves expert, personalized financial guidance—no matter their current income, wealth, or life stage. Unlike many firms that focus exclusively on high-net-worth individuals, we serve a diverse clientele from all professions and walks of life. As a Certified Financial Fiduciary, we are fully committed to putting your best interests first, helping you understand your unique Goals, Passions, and Struggles (GPS), and navigating every phase of your financial journey with confidence.

Whether you’re just starting your career, growing a business, planning for a child’s education, transitioning to an empty nest, or preparing for retirement, our holistic approach ensures you receive the education and coaching needed to become financially secure, responsibly insured, and tax-wise (FIT).

By tailoring our services to your evolving needs, we strive to help you meet today’s priorities while planning for a more secure tomorrow. This inclusive philosophy underscores our promise: every person deserves quality financial planning and guidance that is transparent, unbiased, and always in their best interest.”

Video Link: https://www.youtube.com/embed/UdiDVOHk52I

About Darryl & Alicia Pryor

As a Certified Financial Fiduciary (CFF) and financial well-being strategist, Darryl’s goal is to remove the complexity of financial planning through his coaching and mentorship, accountability, and a “let’s get it done” mindset which he gained through years of self-less service as military, government civilian and private industry servant helping the “good guys” find the “bad guys”.

His true passion, however, has always been in helping others pursue financial, personal, and professional success. This passion is fueled by the recognition that any success he has achieved in life has been through the support and mentorship of family, friends, and close associates. Although he considers himself “just a common, hardworking ordinary guy” who like most has experienced life’s “ups” and “downs,” He attributes the successes he has had to the advice and guidance of those who have poured into me financially, personally, and professionally. It is this level of commitment He will pour into you.

He has been in the financial services business for 15+ years, working primarily with families and business owners. He uses a unique approach that helps people find money they’re currently transferring away unknowingly and unnecessarily.

Below are a few of the areas he enjoys coaching and advising individuals and small businesses with by offering creative and customizable 360-degree solutions tailored to fit their needs:

  • Retirement planning
  • Wealth Management
  • Federal benefits analysis and advisory
  • College planning
  • Tax planning and consultation
  • Income tax resolution with IRS and State
  • Personal/Business insurance consultation and product selection

Learn more: https://www.dnafinancialassociates.com/

Podcast Disclaimer:

This podcast is for informational and educational purposes only and should not be considered financial, legal, or tax advice. The views and opinions shared by the host and any guests are theirs alone and do not necessarily reflect those of any organization. All investments carry risks, and past performance is not a guarantee of future results. Before making any financial decisions or implementing any strategy discussed, please consult a qualified professional who can address your specific situation. The content in this podcast is not a solicitation nor an offer to buy or sell any financial products or services.

Media Contact
Company Name: Marketing Huddle, LLC
Contact Person: Mike Saunders, MBA
Email: Send Email
Phone: 7202323112
Country: United States
Website: https://www.AuthorityPositioningCoach.com

Anxiety by Augusto Cury, PhD, How to Face the Illness of the Century, Overcoming Anxiety in the Modern World

Anxiety is sweeping the globe, affecting people of all ages and walks of life. In his groundbreaking book, Anxiety: How to Face the Illness of the Century (English Edition), internationally renowned psychotherapist and bestselling author Augusto Cury, PhD, tackles this widespread issue head-on. With a unique blend of scientific insight and practical advice, Cury offers readers a roadmap to reclaiming their mental and emotional well-being in the midst of today’s fast-paced, high-pressure world.

The Anxiety Epidemic: Why It’s the Disease of Our Time

In today’s information-saturated society, anxiety has become a universal affliction. More than just occasional worry or stress, it has evolved into what Cury calls the “disease of the century.” Whether it’s young children dealing with school pressures, teenagers grappling with social media, or adults facing the endless demands of work and family, anxiety knows no bounds.

Cury reveals that this condition has been exacerbated by modern life’s relentless pace. The expectation to multitask, coupled with the constant influx of information, leaves individuals feeling overwhelmed and mentally exhausted. In Anxiety: How to Face the Illness of the Century, Cury not only examines the root causes of this issue but also offers solutions to help readers regain control of their mental health.

Introducing Accelerated Thought Syndrome (SPA)

At the heart of Cury’s analysis is the concept of Accelerated Thought Syndrome (SPA). SPA is the psychological phenomenon that fuels much of the anxiety plaguing today’s society. It’s characterized by a relentless barrage of thoughts, which can lead to:

  • Mental fatigue
  • Difficulty concentrating
  • Short-term memory issues
  • Irritability and a sense of being constantly on edge

According to Cury, SPA is the result of living in an age where people are expected to process information faster than ever before. This mental overload creates a breeding ground for anxiety, as the mind struggles to keep up with the demands of daily life. Cury explains how SPA not only affects productivity but also deteriorates emotional well-being and can trigger chronic anxiety and depression.

A Practical Guide to Restoring Mental Peace

Anxiety: How to Face the Illness of the Century is more than just a diagnosis of society’s problems—it’s a step-by-step guide to reclaiming mental tranquility. Cury provides readers with practical techniques to slow down their racing thoughts, manage their emotions, and reduce the grip of anxiety. His methods are backed by years of research and clinical practice, offering tools that anyone can apply to their daily life.

Readers will learn to:

  • Identify the roots of their anxiety: Cury helps readers pinpoint the modern-day pressures that contribute to their stress and mental exhaustion.
  • Implement strategies for mental clarity: From mindfulness practices to breathing exercises, Cury offers simple yet effective techniques for calming the mind and improving focus.
  • Build emotional resilience: By developing coping mechanisms and fostering emotional intelligence, readers can face life’s challenges with greater ease.
  • Embrace mindfulness and live in the present: Cury emphasizes the importance of being present, teaching readers how to enjoy life’s small moments and reconnect with their inner selves.

These practical techniques are not just short-term fixes. They are designed to bring about lasting changes in how readers perceive and respond to stress, ultimately leading to a more balanced and peaceful life.

Why This Book Matters

With anxiety levels at an all-time high, Anxiety: How to Face the Illness of the Century is a timely and essential read. In this book, Cury combines scientific understanding with heartfelt compassion, making it accessible to anyone—whether you are currently struggling with anxiety or seeking to better understand and manage your mental health.

Who Should Read This Book?

  • Those experiencing anxiety, stress, or mental burnout
  • Individuals looking to better understand their own mental patterns and emotional responses
  • Fans of personal development books and psychological self-help
  • Anyone eager to slow down the mental chaos of modern life and find peace of mind

Cury’s approach is not just about treating anxiety but about empowering readers to take control of their lives, recognize their emotional triggers, and cultivate a mindset of calm and resilience.

About the Author

Augusto Cury is one of the world’s most read and celebrated authors, with over 40 million copies of his books sold in more than 70 countries. As a psychiatrist and researcher, he has devoted his career to understanding the human mind and emotional well-being. His work has transformed lives by providing practical solutions to mental health challenges, and he continues to inspire millions with his groundbreaking ideas and accessible writing.

A Path to Mental and Emotional Freedom

If you are ready to stop living in constant worry and take back control of your life, Anxiety: How to Face the Illness of the Century offers the tools you need to break free from the cycle of anxious thinking. Join millions of readers worldwide who have benefited from Augusto Cury’s wisdom, and embark on a journey toward mental and emotional liberation.

Notable works include The Dreams Seller, adapted into film and theater, and The Smartest Man in History. Dr. Cury also founded the “You Are Irreplaceable” program, a free initiative to prevent suicide by offering emotional support.

For further information, review copies, or interviews, please contact:

Email: contato@augustocury.com.br

Website: https://augustocuryinstitucional.com.br/

Media Contact
Company Name: Dr. Augusto Cury
Contact Person: Dr. Augusto Cury
Email: Send Email
Country: Brazil
Website: https://augustocuryinstitucional.com.br/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Anxiety by Augusto Cury, PhD, How to Face the Illness of the Century, Overcoming Anxiety in the Modern World

Excellence Awards 2025 Announced: Celebrating Outstanding Speakers Who Inspire the World

The Excellence Awards are proud to announce the winners of the Speaker of the Year Awards 2025! This year’s winners represent an extraordinary caliber of thought leaders, visionaries, and changemakers who captivate audiences with their words and inspire transformation.

Honoring Excellence

The Excellence Awards, hosted as part of Dr Yasemin Yazan LLC, were established to recognize and celebrate individuals who drive progress and inspire others through their outstanding contributions. The Speaker of the Year Awards spotlight the most impactful voices across industries, highlighting those who use their expertise, passion, and presence to make a lasting difference.

“Great speakers don’t just share ideas; they spark transformation and create impact. This year’s awardees exemplify the power of communication in shaping industries, communities, and the future.” – Dr. Yasemin Yazan, Founder and Editor-in-Chief of the Excellence Awards.

Winners: Speaker of the Year Awards 2025

  • Celebrating the Winners:

  • Ambila Nath – Life Transformation & Intuition

  • Amelia Burke-Garcia – Smart Tech & Health

  • Andi Lonnen – Finance

  • Anita Cleare – Parenting

  • Avalaura Gaither – Holistic Mental Health & Personal Development

  • Ayla Annac – Health Innovation

  • Carolyn Scott – Healthy Lifestyle & Travel

  • Cecilia Hugony – Customer & Employee Experience

  • Christine Gritmon – Personal Branding

  • Claudia Spahr – Motherhood & Leadership

  • Dana Zellers – Leadership & Work-Life-Balance

  • Daniel Burrus – Leadership, AI & Future Trends

  • David Bartley – Mental Health & Suicide Prevention

  • Deborah Levine – Culture & Diversity

  • Dolores Semeraro – Tourism

  • Dr. Namrata Kapur – Diversity, Equity & Inclusion

  • Gaelle Berruel – Visibility & Confidence

  • Gillian Hovell – Ancient History & Archaeology

  • Gina Buckney – Workplace Performance

  • Gina M. Longo – Aviation Safety & Leadership

  • Jean-Louis Fargier – Innovative Use of Music for Wellbeing

  • Jeff Smith – KPI & Business Management

  • Jimmy Clare – Resilience

  • Kate Bishop – Self-Confidence & Productivity

  • Katie Stoddart – Focus & Performance

  • Kelly Charles-Collins – Communication

  • Kelly Knowles – Inner Leadership

  • Lambers Fisher – Multicultural Awareness & Diversity

  • Lee Salz – Sales

  • Marc Schmetkamp – Agile Organizational Development

  • Marcy Pusey – Trauma Recovery

  • Mariam Kaskas – Online Shopping & Customer Experience

  • Michela Quilici – Business Growth & Self-Leadership

  • Nicole Lipkin – Leadership & Workplace Psychology

  • Nikki Watson – Interactive Dance for Social Change

  • Nikki Greenberg – Future Trends & Technologies

  • Patricia Wilkinson – Education & Parenting

  • Peter LaPorta – Motivation & Leadership

  • Peter Radford – Diversity & Equity

  • Pradip Mistry – Post-Career Planning

  • Ruth Pearce – Ethics & Mental Health

  • Sally Hindmarch – Communication Skills

  • Satveer Nijjar – Self-Harm Awareness

  • Sharise Nance – Leadership & Performance

  • Stacey Chillemi – Personal Growth & Business Success

  • Steve Leach – Leadership & Business Growth

  • Tanya Simon-Hall – Women’s Health

  • Tara Furiani – Leadership & Cultural Change

  • Tim Coleman – Business Transformation

  • Toni Boucher – Autism

From leadership and business strategy to personal development and wellness, this year’s winners have demonstrated outstanding ability to engage, educate, and elevate their audiences. Their expertise spans multiple domains, but they all share a common trait: a commitment to making an impact through the power of speech.

Looking Ahead

This year’s winners will be prominently featured in the A-Z Listing of Winners on the Excellence Awards website and honored in the upcoming edition of the Excellence Awards Magazine. Their achievements serve as an inspiration for future generations of speakers, setting a new benchmark for excellence in public and corporate speaking.

“The ability to inspire through words is a rare and invaluable skill. These speakers embody the essence of leadership, motivation, and influence.” – Almaz Andezion, Co-Editor-in-Chief.

Discover more about this year’s inspiring winners and the Excellence Awards at www.excellenceawards.global.

About the Excellence Awards

The Excellence Awards, hosted as part of Dr Yasemin Yazan LLC, are dedicated to recognizing outstanding individuals and organizations that drive progress and innovation across industries. By celebrating excellence in public and corporate speaking, the awards aim to inspire and empower thought leaders worldwide.

The Excellence Awards are proudly presented by Dr. Yasemin Yazan, Mona Tenjo, and Almaz Andezion.

For inquiries, please contact: info@excellenceawards.global.

Media Contact
Company Name: Dr Yasemin Yazan LLC
Contact Person: Dr Yasemin Yazan
Email: Send Email
City: St Petersburg
State: Florida
Country: United States
Website: www.excellenceawards.global

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Excellence Awards 2025 Announced: Celebrating Outstanding Speakers Who Inspire the World

Eosinophilic Esophagitis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Eosinophilic Esophagitis Pipeline Insight” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Eosinophilic Esophagitis pipeline landscape. It covers the Eosinophilic Esophagitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eosinophilic Esophagitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Eosinophilic Esophagitis Pipeline Report to explore emerging therapies, key Eosinophilic Esophagitis Companies, and future Eosinophilic Esophagitis treatment landscapes @ Eosinophilic Esophagitis Pipeline Outlook Report

 

Key Takeaways from the Eosinophilic Esophagitis Pipeline Report

  • In February 2025: AstraZeneca:- The study consists of a screening period of 2 to 8 weeks and a 52-week randomized double-blind placebo-controlled treatment period. After completion of the treatment period, participants will be eligible to participate in an optional active treatment extension period (lasting for 24 weeks), followed by a 12-week off-treatment safety follow-up period. Participants who will not participate in the extension period will participate in a 12-week off-treatment safety follow-up period following completion of the 52-week treatment period.
  • In February 2025:- Children’s Hospital Medical Center, Cincinnati– This is a phase II, open-label trial of Zemaira in participants diagnosed with eosinophilic esophagitis. Potential participants will be screened during a 12-week screening period. Participants will be enrolled based on the presence of active disease and their ability to meet the study inclusion and exclusion criteria. Qualifying participants will receive weekly intravenous infusions of 120 mg/kg body weight dose/week for 4 weeks (for a total of 4 infusions).
  • In February 2025:- Celgene:- The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.
  • DelveInsight’s Eosinophilic Esophagitis pipeline report depicts a robust space with 25+ active players working to develop 30+ pipeline therapies for Eosinophilic Esophagitis treatment.
  • The leading Eosinophilic Esophagitis Companies such as Ellodi Pharmaceuticals, Revolo Biotherapeutics, Aqilion, Bristol-Myers Squibb, EsoCap, Pfizer, Calypso Biotech, Serpin Pharma, Landos Biopharma, and others.
  • Promising Eosinophilic Esophagitis Therapies such as Dupilumab, Tezepelumab, NDX-3315, Barzolvolimab, CC-93538, EP-104IAR, Budesonide, and others.

 

Discover how the Eosinophilic Esophagitis treatment paradigm is evolving. Access DelveInsight’s in-depth Eosinophilic Esophagitis Pipeline Analysis for a closer look at promising breakthroughs @ Eosinophilic Esophagitis Clinical Trials and Studies

 

Eosinophilic Esophagitis Emerging Drugs Profile

  • APT-1011: Ellodi Pharmaceuticals

APT-1011 is a novel, proprietary, once daily, investigational oral disintegrating tablet designed to deliver fluticasone propionate to the esophageal mucosa while minimizing residence time in the oral cavity. In earlier clinical trials, APT-1011 reduced esophageal eosinophil counts and endoscopic findings in adults with a diagnosis of EoE. It is currently in clinical development, following successful completion of FLUTE I and FLUTE II. It has been granted orphan drug status by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Currently the product is in Phase III stage of development for the treatment of Eosinophilic Esophagitis.

 

  • IRL201104: Revolo Biotherapeutics

IRL201104, is uniquely safe and efficacious demonstrating immunoregulatory activity in a number of preclinical models. It has successfully completed Phase I clinical development and has the potential to be the first Immune Resetting Asthma Drug (IMRAD). 1104 is a novel linear peptide, derived from a natural immune-regulatory protein, Mycobacterium tuberculosis Chaperonin 60.1, involved in resetting the immune system. It may provide remission for many allergic diseases. 1104 engages a novel target on macrophages and is a first-in-class modulator of the macrophage response. This response engages not only the effector arm of the immune system, but the regulatory arm as well. Currently the product is in Phase II stage of development for the treatment of patients with eosinophilic esophagitis (EoE) and other Th2 allergic diseases.

 

  • AQ280: Aqilion

AQ280 is an oral, small-molecule, super selective JAK1 inhibitor. JAK1 is an enzyme, a kinase that accelerates inflammatory processes, which, among other things effects allergy and fibrosis. By inhibiting its mechanism, it is possible to reduce symptoms and disease development in chronic inflammatory diseases. Within the Regulus program, Aqilion is developing AQ280, which is a super selective JAK1 inhibitor, as a treatment of the chronic disease eosinophilic esophagitis. Data describing the pharmacokinetic profile, safety and tolerability of the drug candidate was evaluated between every dose escalation. Now, data has been collected for all dose groups and the database has been locked for statistical analysis. Currently the product is in Phase I stage of development for the treatment of patients with eosinophilic esophagitis (EoE).

 

The Eosinophilic Esophagitis pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Eosinophilic Esophagitis with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Eosinophilic Esophagitis Treatment.
  • Eosinophilic Esophagitis Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Eosinophilic Esophagitis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Eosinophilic Esophagitis market.

 

Get a detailed analysis of the latest innovations in the Eosinophilic Esophagitis pipeline. Explore DelveInsight’s expert-driven report today! @ Eosinophilic Esophagitis Unmet Needs

 

Eosinophilic Esophagitis Companies

Ellodi Pharmaceuticals, Revolo Biotherapeutics, Aqilion, Bristol-Myers Squibb, EsoCap, Pfizer, Calypso Biotech, Serpin Pharma, Landos Biopharma, and others.

 

Eosinophilic Esophagitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Intravenous

 

Eosinophilic Esophagitis Products have been categorized under various Molecule types such as

  • Peptide
  • Protein
  • Propylene glycols
  • Cell Therapy

 

Download DelveInsight’s latest report to gain strategic insights into upcoming Eosinophilic Esophagitis Therapies and key Eosinophilic Esophagitis Developments @ Eosinophilic Esophagitis Market Drivers and Barriers, and Future Perspectives

 

Scope of the Eosinophilic Esophagitis Pipeline Report

  • Coverage- Global
  • Eosinophilic Esophagitis Companies- Ellodi Pharmaceuticals, Revolo Biotherapeutics, Aqilion, Bristol-Myers Squibb, EsoCap, Pfizer, Calypso Biotech, Serpin Pharma, Landos Biopharma, and others.
  • Eosinophilic Esophagitis Therapies- Dupilumab, Tezepelumab, NDX-3315, Barzolvolimab, CC-93538, EP-104IAR, Budesonide, and others.
  • Eosinophilic Esophagitis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Eosinophilic Esophagitis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

Which companies are leading the race in Eosinophilic Esophagitis drug development? Find out in DelveInsight’s exclusive Eosinophilic Esophagitis Pipeline Report—access it now! @ Eosinophilic Esophagitis Emerging Drugs and Major Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Eosinophilic Esophagitis: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Eosinophilic Esophagitis – DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. APT-1011: Ellodi Pharmaceuticals
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. IRL201104: Revolo Biotherapeutics
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. AQ280: Aqilion
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug Name: Company Name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Eosinophilic Esophagitis Key Companies
  21. Eosinophilic Esophagitis Key Products
  22. Eosinophilic Esophagitis- Unmet Needs
  23. Eosinophilic Esophagitis- Market Drivers and Barriers
  24. Eosinophilic Esophagitis- Future Perspectives and Conclusion
  25. Eosinophilic Esophagitis Analyst Views
  26. Eosinophilic Esophagitis Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Eosinophilic Esophagitis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

Sarcopenia Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Epidemiology, Medication, NDA Approvals, Pipeline, Therapeutics and Companies by DelveInsight

“Sarcopenia Drugs Market”
Sarcopenia companies are MyMD Pharmaceuticals, Biophytis, Dystrogen Therapeutics, Rejuvenate Biomed, Oncocross Therapeutics, OPKO health, NMD Pharma, Rubedo Life Sciences, Immunoforge, and others.

(Albany, USA) DelveInsight’s “Sarcopenia Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of Sarcopenia, historical and forecasted epidemiology as well as the Sarcopenia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Sarcopenia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Sarcopenia market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Sarcopenia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Sarcopenia market.

 

Request for a Free Sample Report @ Sarcopenia Market Forecast

 

Some of the Key facts of Sarcopenia Market are:

  • According to DelveInsight’s analysis, sarcopenia market size in the 7MM is expected to grow at a significant CAGR by 2034.
  • The total diagnosed prevalent cases of sarcopenia in the 7MM was 27.4 million cases in 2023 and this number is forecasted to climb at a significant CAGR in the research period (2020–2034).
  • The Sarcopenia market size in the 7MM reached approximately USD 2,731 million in 2022. Projections indicate a substantial growth during the forecast period.
  • Amongst the EU-5 countries, Italy had the highest number of cases followed by Germany with 3,556,282 and 3,194,532 cases respectively. Spain accounted for least number of sarcopenia cases in 2021.
  • Japan accounted for 3,104,585 cases sarcopenia in 2021, which accounted for approximately 9% of the total 7MM prevalent cases of sarcopenia.
  • According to DelveInsight, males are affected more as compared to females in case of sarcopenia.
  • Leading Sarcopenia companies working in the market are MyMD Pharmaceuticals, Biophytis, Dystrogen Therapeutics, Rejuvenate Biomed, Oncocross Therapeutics, OPKO health, NMD Pharma, Rubedo Life Sciences, Immunoforge, and others.
  • Sarcopenia therapies expected to launch are Sarconeos (BIO101), MYMD-1, and others.
  • In August 2024, TNF Pharmaceuticals, Inc. announced plans to move forward with its lead program, MYMD-1, into fully funded mid-stage clinical trials. The upcoming studies will further investigate the drug’s effectiveness in treating sarcopenia/frailty, following statistically significant positive outcomes from a previous Phase II trial.

 

Sarcopenia Overview

Sarcopenia is a progressive and generalized skeletal muscle disorder characterized by the loss of muscle mass, strength, and function. It primarily affects older adults, contributing significantly to frailty, disability, and reduced quality of life. Sarcopenia can also be associated with chronic diseases, malnutrition, and a sedentary lifestyle.

The onset of sarcopenia is influenced by a combination of age-related changes in muscle tissue, hormonal shifts, inflammation, and decreased physical activity. Muscle fibers shrink and are lost, leading to decreased muscle mass and strength. Additionally, there is often a reduction in the body’s ability to synthesize muscle proteins, further exacerbating muscle loss.

Diagnosis of sarcopenia typically involves assessing muscle mass, strength, and physical performance. Tools like dual-energy X-ray absorptiometry (DEXA) scans, grip strength measurements, and gait speed tests are commonly used.

Managing sarcopenia involves a multifaceted approach, including resistance and aerobic exercise to improve muscle strength and function, nutritional interventions such as increased protein intake, and addressing underlying health conditions. In some cases, pharmacological treatments may be considered.

Early identification and intervention are crucial in mitigating the impacts of sarcopenia, helping to maintain independence and improve the overall quality of life in affected individuals. Ongoing research aims to better understand the mechanisms of sarcopenia and develop more effective treatments.

 

Learn more about Sarcopenia treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ Sarcopenia Prevalence

 

Sarcopenia Market

The Sarcopenia market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Sarcopenia market trends by analyzing the impact of current Sarcopenia therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Sarcopenia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Sarcopenia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Sarcopenia market in 7MM is expected to witness a major change in the study period 2020-2034.

 

Sarcopenia Epidemiology

The Sarcopenia epidemiology section provides insights into the historical and current Sarcopenia patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Sarcopenia market report also provides the diagnosed patient pool, trends, and assumptions.

 

Explore more about Sarcopenia Epidemiology @ Sarcopenia Market Dynamics

 

Sarcopenia Drugs Uptake

This section focuses on the uptake rate of the potential Sarcopenia drugs recently launched in the Sarcopenia market or expected to be launched in 2020-2034. The analysis covers the Sarcopenia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Sarcopenia Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Sarcopenia market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Some of the Sarcopenia companies and therapies:

  • Biophytis: Sarconeos (BIO101)
  • Rejuvenate Biomed: RJx-01
  • Lipocine Inc: LPCN 1148
  • And Many Others

 

Sarcopenia Pipeline Development Activities

The Sarcopenia report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Sarcopenia key players involved in developing targeted therapeutics.

 

Request for a sample report to understand more about the Sarcopenia pipeline development activities @ Sarcopenia Treatment Market

 

Sarcopenia Therapeutics Assessment

Major key companies are working proactively in the Sarcopenia Therapeutics market to develop novel therapies which will drive the Sarcopenia treatment markets in the upcoming years are MyMD Pharmaceuticals, Biophytis, Dystrogen Therapeutics, Rejuvenate Biomed, Oncocross Therapeutics, OPKO health, NMD Pharma, Rubedo Life Sciences, Immunoforge, and others.

 

Learn more about the emerging Sarcopenia therapies & key companies @ Sarcopenia Clinical Trials and FDA Approvals

 

Sarcopenia Report Key Insights

1. Sarcopenia Patient Population

2. Sarcopenia Market Size and Trends

3. Key Cross Competition in the Sarcopenia Market

4. Sarcopenia Market Dynamics (Key Drivers and Barriers)

5. Sarcopenia Market Opportunities

6. Sarcopenia Therapeutic Approaches

7. Sarcopenia Pipeline Analysis

8. Sarcopenia Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Sarcopenia Market

 

Table of Contents

1. Key Insights

2. Executive Summary

3. Sarcopenia Competitive Intelligence Analysis

4. Sarcopenia Market Overview at a Glance

5. Sarcopenia Disease Background and Overview

6. Sarcopenia Patient Journey

7. Sarcopenia Epidemiology and Patient Population

8. Sarcopenia Treatment Algorithm, Current Treatment, and Medical Practices

9. Sarcopenia Unmet Needs

10. Key Endpoints of Sarcopenia Treatment

11. Sarcopenia Marketed Products

12. Sarcopenia Emerging Therapies

13. Sarcopenia Seven Major Market Analysis

14. Attribute Analysis

15. Sarcopenia Market Outlook (7 major markets)

16. Sarcopenia Access and Reimbursement Overview

17. KOL Views on the Sarcopenia Market

18. Sarcopenia Market Drivers

19. Sarcopenia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/aacr-annual-meeting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Sarcopenia Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Epidemiology, Medication, NDA Approvals, Pipeline, Therapeutics and Companies by DelveInsight

Anxiety by Augusto Cury, PhD, How to Face the Illness of the Century

The Silent Epidemic of the 21st Century: Understanding and Overcoming Anxiety

Do you suffer from constant worry? Are you perpetually exhausted? Do you find yourself forgetting things, struggling with insomnia, or feeling irritable? If so, you are not alone—welcome to the “disease of the century.”

In today’s fast-paced world, anxiety has become a universal affliction. Children, teenagers, adults, and the elderly—all of us, to varying degrees, are grappling with the traps of anxious thinking. The relentless influx of information, the pressure to multitask, and the accumulation of worries have devastating effects on our physical and psychological well-being.

In Anxiety: How to Face the Illness of the Century, internationally renowned psychotherapist and best-selling author Augusto Cury delves deep into the causes and symptoms of what he terms the Accelerated Thought Syndrome (SPA). With his expertise, Cury offers a guide to help you navigate your inner world, recognize your vulnerabilities, correct your path, and take control of your own life story.

Understanding Accelerated Thought Syndrome (SPA)

Augusto Cury introduces readers to the concept of SPA, a psychological phenomenon that has become increasingly prevalent in our modern age. SPA is characterized by the relentless speed of our thoughts, which leads to mental exhaustion, a lack of focus, memory issues, and a constant state of unease. This condition is fueled by the overwhelming demands of contemporary life, where we are constantly bombarded with information, required to juggle multiple tasks, and pressured to meet high expectations.

Cury explains that SPA is not just a fleeting condition but a chronic issue that can severely impact our quality of life. It affects our ability to enjoy the present moment, diminishes our emotional resilience, and can lead to a host of physical and mental health problems, including anxiety, depression, and burnout.

A Guide to Reclaiming Your Mental and Emotional Well-being

Anxiety is not just a diagnosis; it is a call to action. Augusto Cury provides readers with practical techniques to slow down their thoughts, manage their emotions, and restore their mental balance. Through a series of exercises and reflections, Cury teaches you how to break free from the vicious cycle of anxious thinking and regain control over your life.

In this book, you will learn:

  • The roots of anxiety: Discover how modern life contributes to the rise of anxiety and how SPA manifests in our daily lives.
  • Techniques for mental tranquility: Explore strategies to decelerate your thoughts, improve concentration, and enhance memory.
  • Emotional resilience: Build the skills necessary to cope with stress, manage your emotions, and cultivate a positive mindset.
  • Mindfulness and self-awareness: Learn how to live in the present moment, appreciate the simple pleasures of life, and reconnect with your inner self.

Cury’s insights are grounded in years of clinical experience and research, offering readers a comprehensive approach to understanding and overcoming anxiety. His methods are accessible and effective, making this book a valuable resource for anyone seeking to improve their mental and emotional health.

Why You Should Read This Book

If you are tired of living in a constant state of worry, if you long to escape the mental prison of anxiety, Anxiety: How to Face the Illness of the Century is the book for you. Augusto Cury’s practical advice and profound insights will empower you to take control of your thoughts, manage your emotions, and rediscover the joy of living.

Join millions of readers around the world who have benefited from Cury’s teachings and embark on a journey towards mental and emotional freedom. This book is not just a read—it’s a path to a better, more peaceful life.

About the Author: Dr. Augusto Cury

Dr. Augusto Cury is a renowned psychiatrist, bestselling author, and creator of the Multifocal Intelligence Theory (MIT), a groundbreaking framework for understanding human thought processes. With over 40 million copies of his books sold in Brazil and his works available in more than 70 countries, Dr. Cury’s influence spans globally. His educational and emotional management programs have reached hundreds of thousands across Brazil, empowering people to manage stress and emotions for personal and professional growth.

Notable works include The Dreams Seller, adapted into film and theater, and The Smartest Man in History. Dr. Cury also founded the “You Are Irreplaceable” program, a free initiative to prevent suicide by offering emotional support.

For further information, review copies, or interviews, please contact:

Email: contato@augustocury.com.br

Website: https://augustocuryinstitucional.com.br/

Media Contact
Company Name: Dr. Augusto Cury
Contact Person: Dr. Augusto Cury
Email: Send Email
Country: Brazil
Website: https://augustocuryinstitucional.com.br/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Anxiety by Augusto Cury, PhD, How to Face the Illness of the Century

Inspire Franchise Empowers Med Spas with a Proven, All-Natural, Doctor-Guided Program

““Our program was designed to give healthcare providers a simple, yet highly effective weight loss solution that delivers real, lasting results,” said Dr. Marty Nalda. “With a personalized, one-to-one approach and advanced technology-driven tracking, we ensure that each patient receives tailored support for sustainable weight loss. By focusing on metabolic health and long-term lifestyle changes, we offer a safe solution that truly works—without extreme diets or medications.””
For med spa owners, Inspire Weight Loss offers a proven, all-natural weight loss program that enhances client results and boosts revenue. Designed to address metabolic health, inflammation, and long-term lifestyle changes, it seamlessly integrates with aesthetic treatments to deliver lasting transformations. This turnkey, doctor-designed program meets the growing demand for safe, sustainable weight loss solutions, helping med spas thrive while improving client satisfaction.

Pembroke Pines, FL – February 17, 2025 – Inspire Weight Loss, a doctor-designed weight loss program, is revolutionizing the healthcare industry by providing med spa owners with a turnkey, all-natural weight loss solution. This program not only helps patients achieve lasting weight loss results but also creates a new, highly profitable revenue stream for providers.

With obesity rates on the rise and the growing demand for safe, sustainable weight loss solutions, Inspire Weight Loss delivers an effective, structured system that seamlessly integrates into existing healthcare practices. Whether patients are on GLP-1 medications (such as Ozempic or Wegovy), don’t qualify for them, or prefer a holistic, all-natural approach, this program offers a customized, results-driven weight loss solution—without the need for extreme dieting or surgery.

A Game-Changer for Medical Spas

For med spa owners, adding a proven weight loss program can significantly enhance client results while diversifying revenue streams. Inspire Weight Loss is designed to address the root causes of weight gain, focusing on metabolic health, inflammation reduction, and long-term lifestyle changes. By integrating this all-natural, doctor-designed program, med spas can offer a high-demand service that complements aesthetic treatments and helps clients achieve lasting transformations—all while increasing profitability.

According to Dr. Marty Nalda, Co-Founder of Inspire Weight Loss, this evidence-based, all-natural approach is what sets Inspire apart from other weight loss programs.

“Our program was designed to give healthcare providers a simple, yet highly effective weight loss solution that delivers real, lasting results,” said Dr. Marty Nalda. “With a personalized, one-to-one approach and advanced technology-driven tracking, we ensure that each patient receives tailored support for sustainable weight loss. By focusing on metabolic health and long-term lifestyle changes, we offer a safe solution that truly works—without extreme diets or medications.”

A Response to the Growing Demand for Alternative Weight Loss Solutions

Many patients seeking weight loss turn to GLP-1 medications like Ozempic or Wegovy. While these drugs can be effective, they aren’t suitable for everyone due to medical restrictions, side effects, or cost. Inspire Weight Loss bridges the gap by providing a non-pharmaceutical, natural alternative that focuses on sustainable weight loss, metabolic balance, and long-term wellness.

Additionally, many patients using GLP-1 medications require nutritional and metabolic support to maintain their results. Inspire Weight Loss complements and enhances their weight loss journey, making it an ideal program for both GLP-1 users and non-users alike.

Why Providers Are Choosing Inspire Weight Loss:

• Works for Every Patient – Supports those on GLP-1 medications, those who don’t qualify, and individuals seeking an all-natural weight loss solution.

• All-Natural, Sustainable Approach – No hormones, no extreme dieting—just real, lasting results driven by science-backed protocols.

• Turnkey & Easy to Implement – Inspire Weight Loss provides full setup, training, and ongoing marketing support, allowing healthcare providers to seamlessly integrate the program into their existing practice.

• Proven, Doctor-Designed System – Aligns with holistic wellness, functional medicine, and evidence-based health practices to ensure optimal patient outcomes.

• High-Demand, Cash-Based Service – Provides an additional revenue stream with strong patient demand and repeat clients seeking long-term weight management solutions.

A Simple, Proven Path to Success

Unlike other weight loss programs that require complex integrations or high startup costs, Inspire Weight Loss is designed to be seamless and highly effective from day one.

How it Works:

1. Turnkey setup – Everything needed to launch the program effortlessly is provided.

2. Hands-on training – Comprehensive training on clinical protocol, patient management, sales, and marketing.

3. Ongoing marketing assistance – Pre-built marketing materials, ad campaigns, and patient acquisition strategies to attract new clients.

4. Measurable patient success – Real, trackable results that enhance patient outcomes while boosting practice revenue.

The Future of Weight Loss in Healthcare

As the healthcare industry continues to evolve, weight loss and metabolic health are becoming top priorities for both providers and patients. By adopting Inspire Weight Loss, healthcare professionals can stay ahead of the curve, offering science-backed, natural weight loss solutions that fit within modern healthcare and wellness models.

Join the Inspire Weight Loss Movement

Medical spas looking to expand their services, improve patient outcomes, and increase revenue can take advantage of this high-demand opportunity today.

Media Contact
Company Name: Inspire Franchise, LLC
Contact Person: Dr. Marty Nalda
Email: Send Email
Phone: (407) 837-3555
Address:1721 123rd Avenue
City: Pembroke Pines
State: FL
Country: United States
Website: https://inspireweightloss.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Inspire Franchise Empowers Med Spas with a Proven, All-Natural, Doctor-Guided Program